Add-on Mirabegron in Pediatric Patients With Refractory Overactive Bladder
Status:
Completed
Trial end date:
2016-06-01
Target enrollment:
Participant gender:
Summary
The objective is to evaluate the efficacy and safety of adding mirabegron to an
antimuscarinic to treat urinary incontinence in children with Overactive Bladder that are
refractory to antimuscarinics.
Phase:
Phase 3
Details
Lead Sponsor:
Centre Hospitalier Universitaire de Québec, CHU de Québec CHU de Quebec-Universite Laval